IGF2BP3 and arthritic joint disease: In WT arthritis mice, the serum contents of TNF‐α and IL‐6 decreased with CEL treatment; the IGF2BP3 KO group and the IGF2BP3 KO plus CEL group presented the same trend (Figure 7F,G).